30 Results

People

  1. Perales
    Perales
  2. Boelens
    Boelens
  3. Dahi
    Dahi
  4. Shouval
    Shouval
  5. Lin
    Lin
  6. Palomba
    Palomba
  7. Salles
    Salles
  8. Shah
    Shah
  9. Abdel-Wahab
    Abdel-Wahab
  10. Alarcon Tomas
    Alarcon Tomas

Groups

  1. Department of Medicine (23)
  2. Hematologic Malignancies, Division of (21)
  3. Center for Hematologic Malignancies (15)
  4. Bone Marrow Transplant (9)
  5. Tow Center for Developmental Oncology (TCDO) (7)
  6. GSK Faculty (6)
  7. Graduate Medical Education (5)
  8. MSK Grad Students (5)
  9. Survivorship Research (5)
  10. CTCR Scholars (4)
  1. "cell- and tissue-based therapy"
Formats
  1. Journal Article (14)
  2. Guidelines (6)
  3. Editorial (5)
  4. Review (5)
Groups
  1. Department of Medicine (23)
  2. Hematologic Malignancies, Division of (21)
  3. Center for Hematologic Malignancies (15)
  4. Bone Marrow Transplant (9)
  5. Tow Center for Developmental Oncology (TCDO) (7)
  6. GSK Faculty (6)

More Groups

People
  1. Miguel-Angel Perales (7)
  2. Jaap Jan Boelens (4)
  3. Parastoo Dahi (4)
  4. Roni Shouval (4)
  5. Gilles Salles (3)
  6. Gunjan Shah (3)

More People

Years
  1. 2025 (2)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (7)
  5. 2014 (1)
Publications
  1. Transplantation and Cellular Therapy (12)
  2. Cytotherapy (3)
  3. Nature Medicine (2)
  4. Acta Haematologica (1)
  5. Blood Reviews (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Elsevier Inc. (13)
  2. Nature Publishing Group (6)
  3. Elsevier Science Ltd. (3)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sham surgery for the trialing of cell-based therapies to the CNS may not be necessary
    Editorial

    Tabar, V.; Barker, R. A.
    Cell Stem Cell (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cell therapy for myeloma: Where are we now and what is needed to move chimeric antigen receptor T cells forward to earlier lines of therapy? Expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Guidelines

    Anderson, L. D. Jr; Dhakal, B.; Jain, T.; Oluwole, O. O.; Shah, G. L.; Sidana, S.; Perales, M. A.; Pasquini, M. C.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
    Journal Article

    Fried, S.; Shkury, E.; Itzhaki, O.; Sdayoor, I.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Shouval, R.; Kedmi, M.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
    Journal Article

    Ryan, C. E.; Zon, R. L.; Redd, R.; Fisher, D. C.; Shouval, R.; Kumar, A.; Crombie, J. L.; Sadrzadeh, H.; Kim, A. I.; Nayak, L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • The role of chimeric antigen receptor T-cell therapy in the era of bispecific antibodies
    Review

    Nath, K.; Mailankody, S.; Usmani, S. Z.
    Hematology/Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: Phase 1/2 trial interim results
    Journal Article

    Hassan, R.; Butler, M.; O’Cearbhaill, R. E.; Oh, D. Y.; Johnson, M.; Zikaras, K.; Smalley, M.; Ross, M.; Tanyi, J. L.; Ghafoor, A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS)
    Review

    Bewersdorf, J. P.; Xie, Z.; Bejar, R.; Borate, U.; Boultwood, J.; Brunner, A. M.; Buckstein, R.; Carraway, H. E.; Churpek, J. E.; Daver, N. G.; more...
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Frequently asked questions about Mpox (formerly Monkeypox disease) for hematopoietic cell transplantation and chimeric antigen receptor T cell recipients from the American Society for Transplantation and Cellular Therapy
    Review

    Ford, E. S.; Papanicolaou, G. A.; Dadwal, S. S.; Pergam, S.; Spallone, A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Paving the road for chimeric antigen receptor T cells: American Society for Transplantation and Cellular Therapy 80/20 task force consensus on challenges and solutions to improving efficiency of clinical center certification and maintenance of operations for commercially approved immune effector cell therapies
    Journal Article

    Nikiforow, S.; Frigault, M. J.; Frey, N. V.; Gardner, R. A.; Komanduri, K. V.; Perales, M. A.; Kebriaei, P.; Warkentin, P. I.; Pasquini, M.; Aho, J. L.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save